Amphastar Pharmaceuticals, Inc. SEC filings AMPH

Amphastar Pharmaceuticals, Inc. has 957 filings in SEC EDGAR's recent list, going back to Feb 11, 2005. Its latest annual report, Form ARS, was filed on Apr 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Amphastar Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 5, 2026 —
144 Notice of proposed sale Nov 4, 2026 —
4 Insider transaction Sep 23, 2026 Sep 21, 2026
144 Notice of proposed sale Sep 21, 2026 —
4 Insider transaction Sep 17, 2026 Sep 16, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 1, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
4 Insider transaction Aug 12, 2026 Aug 11, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
144 Notice of proposed sale Aug 11, 2026 —
144 Notice of proposed sale Aug 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 14, 2026 —
4 Insider transaction Jul 13, 2026 Jul 9, 2026
3 Initial insider ownership Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jun 3, 2026 Aug 19, 2024
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Dec 18, 2025 Dec 17, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
144 Notice of proposed sale Dec 11, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Nov 28, 2025 —
4 Insider transaction Nov 25, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 17, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 13, 2025 —
4 Insider transaction Nov 5, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 3, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 2, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 1, 2025 —
4 Insider transaction Sep 3, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
4 Insider transaction Aug 4, 2025 Aug 1, 2025
144 Notice of proposed sale Aug 1, 2025 —
4 Insider transaction Jul 22, 2025 Jul 18, 2025
3 Initial insider ownership Jul 22, 2025 Jul 18, 2025
4 Insider transaction Jul 3, 2025 Jul 2, 2025
144 Notice of proposed sale Jul 2, 2025 —
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
144 Notice of proposed sale Jun 2, 2025 —
4 Insider transaction May 20, 2025 May 19, 2025
4 Insider transaction May 2, 2025 May 1, 2025
144 Notice of proposed sale May 1, 2025 —
4 Insider transaction Apr 2, 2025 Apr 1, 2025
144 Notice of proposed sale Apr 1, 2025 —
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
144 Notice of proposed sale Mar 6, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
144 Notice of proposed sale Dec 9, 2024 —
4 Insider transaction Nov 13, 2024 Nov 12, 2024
4 Insider transaction Nov 13, 2024 Nov 12, 2024
4 Insider transaction Nov 12, 2024 Nov 11, 2024
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
4 Insider transaction Nov 8, 2024 Nov 6, 2024
4 Insider transaction Nov 8, 2024 Nov 6, 2024
144 Notice of proposed sale Nov 6, 2024 —
144 Notice of proposed sale Nov 6, 2024 —
4 Insider transaction Sep 17, 2024 Sep 13, 2024
4 Insider transaction Sep 16, 2024 Sep 13, 2024
4 Insider transaction Sep 6, 2024 Sep 5, 2024
144 Notice of proposed sale Sep 5, 2024 —
4 Insider transaction Aug 27, 2024 Aug 26, 2024
144 Notice of proposed sale Aug 26, 2024 —
4 Insider transaction Aug 13, 2024 Aug 12, 2024
144 Notice of proposed sale Aug 12, 2024 —
4 Insider transaction Aug 2, 2024 Jul 31, 2024
144 Notice of proposed sale Jul 31, 2024 —
4 Insider transaction Jun 28, 2024 Jun 27, 2024
144 Notice of proposed sale Jun 27, 2024 —
4 Insider transaction Jun 11, 2024 Jun 10, 2024
4 Insider transaction Jun 11, 2024 Jun 10, 2024
144 Notice of proposed sale Jun 10, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 4, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
144 Notice of proposed sale Jun 3, 2024 —
4 Insider transaction May 21, 2024 May 19, 2024
4 Insider transaction May 2, 2024 May 1, 2024
144 Notice of proposed sale May 1, 2024 —
4 Insider transaction Apr 2, 2024 Apr 1, 2024
144 Notice of proposed sale Apr 1, 2024 —
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 5, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
144 Notice of proposed sale Mar 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Mar 6, 2024 —
144 Notice of proposed sale Mar 5, 2024 —
4 Insider transaction Mar 4, 2024 Mar 1, 2024
144 Notice of proposed sale Mar 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
4 Insider transaction Feb 2, 2024 Feb 1, 2024
144 Notice of proposed sale Feb 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 17, 2024 —
4 Insider transaction Jan 11, 2024 Jan 10, 2024
4 Insider transaction Jan 10, 2024 Jan 8, 2024
144 Notice of proposed sale Jan 10, 2024 —
144 Notice of proposed sale Jan 9, 2024 —
144 Notice of proposed sale Jan 8, 2024 —
4 Insider transaction Jan 3, 2024 Jan 2, 2024
144 Notice of proposed sale Jan 2, 2024 —
4 Insider transaction Dec 5, 2023 Dec 1, 2023
4 Insider transaction Dec 4, 2023 Dec 1, 2023
144 Notice of proposed sale Dec 1, 2023 —
4 Insider transaction Nov 20, 2023 Nov 17, 2023
144 Notice of proposed sale Nov 17, 2023 —
4 Insider transaction Nov 16, 2023 Nov 14, 2023
4 Insider transaction Nov 15, 2023 Nov 13, 2023
4 Insider transaction Nov 15, 2023 Nov 14, 2023
144 Notice of proposed sale Nov 14, 2023 —
144 Notice of proposed sale Nov 13, 2023 —
144 Notice of proposed sale Nov 13, 2023 —
4 Insider transaction Nov 2, 2023 Nov 1, 2023
144 Notice of proposed sale Nov 1, 2023 —
4 Insider transaction Oct 3, 2023 Oct 2, 2023
144 Notice of proposed sale Oct 2, 2023 —
4 Insider transaction Sep 8, 2023 Sep 6, 2023
144 Notice of proposed sale Sep 6, 2023 —
4 Insider transaction Aug 29, 2023 Aug 28, 2023
144 Notice of proposed sale Aug 28, 2023 —
4 Insider transaction Aug 21, 2023 Aug 18, 2023
4 Insider transaction Aug 16, 2023 Aug 15, 2023
4 Insider transaction Aug 16, 2023 Aug 15, 2023
144 Notice of proposed sale Aug 15, 2023 —
144 Notice of proposed sale Aug 15, 2023 —
4 Insider transaction Jun 21, 2023 Jun 20, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
144 Notice of proposed sale Jun 15, 2023 —
4 Insider transaction Jun 14, 2023 Jun 13, 2023
4 Insider transaction Jun 12, 2023 Jun 10, 2023
4 Insider transaction Jun 7, 2023 Jun 5, 2023
4 Insider transaction Jun 7, 2023 Jun 5, 2023
4 Insider transaction Jun 7, 2023 Jun 5, 2023
4 Insider transaction Jun 7, 2023 Jun 5, 2023
4 Insider transaction Jun 7, 2023 Jun 5, 2023
4 Insider transaction Jun 7, 2023 Jun 5, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AMPH (Nasdaq)
Fiscal year ends
December 31
Headquarters
Rancho Cucamonga, CA
SEC filer status
Large accelerated filer
SEC CIK
1297184

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.